Skip to main content

Combined Immunodeficiency Disease, X-linked clinical trials at UCSF
1 in progress, 1 open to new patients

  • Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

    open to eligible males ages up to 24 months

    SCID-X1 is a genetic disorder of blood cells caused by DNA changes in a gene that is required for the normal development of the human immune system. The purpose of this study is to determine if a new method, called lentiviral gene transfer, can be used to treat SCID-X1. This method involves transferring a normal copy of the common gamma chain gene into the participant's bone marrow stem cells. The investigators want to determine if the procedure is safe, whether it can be done according to the methods they have developed, and whether the procedure will provide a normal immune system for the patient. It is hoped that this type of gene transfer may offer a new way to treat children with SCID-X1 that do not have a brother or sister who can be used as a donor for stem cell transplantation.

    San Francisco, California and other locations